FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/071821 [Registered on: 02/08/2024] Trial Registered Prospectively
Last Modified On: 01/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Nutraceutical 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   The effects of Full Enteral Feeding since D1 of life versus Conventional Enteral Feeding in stable infants of 28 to 31 weeks of period of gestation- A Randomized Controlled Trial 
Scientific Title of Study   Early Total Enteral Feeding versus Conventional Enteral Feeding in stable very preterm infants 28+0 to 31+6 weeks of period of gestation A Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Madhurima Karak 
Designation  Junior Resident, Paediatrics 
Affiliation  Ramakrishna Mission Seva Pratishthan, Vivekananda Institute of Medical Sciences, Kolkata 
Address  Department of Paediatrics Ramakrishna Mission Seva Pratishthan, Vivekananda Institute of Medical Sciences, 99, Sarat Bose Road, Kolkata
99, Sarat Bose Road, Kolkata
Kolkata
WEST BENGAL
700026
India 
Phone  9434378070  
Fax    
Email  madhurimakarak36@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Tapabrata Chatterjee 
Designation  Professor and Head, Paediatrics 
Affiliation  Ramakrishna Mission Seva Pratishthan, Vivekananda Institute of Medical Sciences, Kolkata 
Address  Ramakrishna Mission Seva Pratishthan, Vivekananda Institute of Medical Sciences, 99, Sarat Bose Road, Kolkata
99, Sarat Bose Road, Kolkata
Kolkata
WEST BENGAL
700026
India 
Phone  9831213723  
Fax    
Email  tapo.chattopadhyay@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Madhurima Karak 
Designation  Junior Resident, Paediatrics 
Affiliation  Ramakrishna Mission Seva Pratishthan, Vivekananda Institute of Medical Sciences, Kolkata 
Address  Department of Paediatrics, Ramakrishna Mission Seva Pratishthan, Vivekananda Institute of Medical Sciences, 99, Sarat Bose Road, Kolkata
99, Sarat Bose Road, Kolkata
Kolkata
WEST BENGAL
700026
India 
Phone  9434378070  
Fax    
Email  madhurimakarak36@gmail.com  
 
Source of Monetary or Material Support  
Department of Paediatrics,Ramakrishna Mission Seva Pratishthan, Vivekanada Institute of Medical Sciences,99 Sarat Bose Road, Kolkata 700026 
 
Primary Sponsor  
Name  Ramakrishna Mission Seva Pratishthan Vivekanada Institute of Medical Sciences Kolkata 
Address  99,Sarat Bose Road, Kolkata 700026 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Madhurima Karak  Ramakrishna Mission Seva Pratishthan, Kolkata  Department of Paediatrics, 2nd Floor, 99, Sarat Bose Road, Kolkata 700026
Kolkata
WEST BENGAL 
9434378070

madhurimakarak36@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Institutional Ethics Committee, Ramakrishna Mission Seva Pratishthan, Kolkata  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: P073||Preterm [premature] newborn [other],  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Control Group (Conventional Enteral Feeding)  Approximately 20 mL/kg/day enteral feed to be given 2 or 3 hourly to preterm infants since their D1 of life. Rest of the total fluid requirements will be in the form of intravenous fluid. Feed will be gradually advanced as per their tolerance till they get discharged from NICU 
Intervention  Trial Group (Early Total Enteral Feeding)  According to Total Fluid Requirements, full enteral feed i.e. 80 mL/kg/day feed to be introduced to the preterm infants 2 or 3 hourly since D1 of life and gradually advanced till the time they get discharged from NICU 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  28.00 Day(s)
Gender  Both 
Details  1.Neonates of POG 28+0 to 31+6 weeks
2.Haemodynamically stable
3.Admitted in Inborn NICU 
 
ExclusionCriteria 
Details  1. Babies with significant congenital anomalies
2. Less than 1 kg birth weight
3. Less than 28 weeks / more than 32 weeks POG
4. Babies with shock requiring inotropic support
5. APGAR score less than 5/10 at 10 min of life
6. significant hypoglycemia 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Postnatal age at attaining 150 mL/kg/day feed  At the time of discharge from NICU 
 
Secondary Outcome  
Outcome  TimePoints 
1. Episodes of feed intolerance
2. Incidence of sepsis and necrotizing enterocolitis
3. Duration of hospital stay 
At the time of discharge from NICU 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   In this study, 28+0 to 31+6 weeker haemodynamically stable babies admitted at inborn NICU will be included. According to total fluid requirements, trial group will be introduced full enteral feed since D1 of life and the control group will be introduced 20 mL/kg/day enteral feed; whereas rest of the requirement will be met in the form of intravenous fluid. As per tolerance of feed of babies, feed will be advanced and primary outcome will be assessed in terms of postnatal age when 150 mL/kg/ day feed is reached. The two groups will be compared by means of episodes of feed intolerance, incidence of sepsis and necrotizing enterocolitis as well as duration of hospital stay. 
Close